Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity
Anna Bal‐Price, M.E. Meek
Pharmacology & Therapeutics (2017) Vol. 179, pp. 84-95
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Micro- and nano-plastics activation of oxidative and inflammatory adverse outcome pathways
Moyan Hu, Dušan Palić
Redox Biology (2020) Vol. 37, pp. 101620-101620
Open Access | Times Cited: 417
Advancing Computational Toxicology in the Big Data Era by Artificial Intelligence: Data-Driven and Mechanism-Driven Modeling for Chemical Toxicity
Heather L. Ciallella, Hao Zhu
Chemical Research in Toxicology (2019) Vol. 32, Iss. 4, pp. 536-547
Open Access | Times Cited: 174
Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity
Anna Bal‐Price
ALTEX (2018), pp. 306-352
Open Access | Times Cited: 169
Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease
Chander K. Negi, Pavel Babica, Lola Bajard, et al.
Metabolism (2021) Vol. 126, pp. 154925-154925
Open Access | Times Cited: 163
Reproductive and Developmental Toxicology
Laura M. Carlson, Catheryne Chiang, Andrew K. Hotchkiss, et al.
Patty's Toxicology (2023), pp. 1-46
Closed Access | Times Cited: 57
Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods
Anna Bal‐Price, Francesca Pistollato, Magdalini Sachana, et al.
Toxicology and Applied Pharmacology (2018) Vol. 354, pp. 7-18
Open Access | Times Cited: 137
Toxicogenomics: A 2020 Vision
Zhichao Liu, Ruili Huang, Ruth Roberts, et al.
Trends in Pharmacological Sciences (2018) Vol. 40, Iss. 2, pp. 92-103
Open Access | Times Cited: 110
Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept
Francesca Pistollato, Emilio Mendoza de Gyves, Donatella Carpi, et al.
Environmental Health (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 89
Early life exposure to air pollution particulate matter (PM) as risk factor for attention deficit/hyperactivity disorder (ADHD): Need for novel strategies for mechanisms and causalities
Oddvar Myhre, Marit Låg, Gro D. Villanger, et al.
Toxicology and Applied Pharmacology (2018) Vol. 354, pp. 196-214
Closed Access | Times Cited: 87
Lead (Pb) and neurodevelopment: A review on exposure and biomarkers of effect (BDNF, HDL) and susceptibility
Claudia Gundacker, Martin Forsthuber, Tamás Szigeti, et al.
International Journal of Hygiene and Environmental Health (2021) Vol. 238, pp. 113855-113855
Open Access | Times Cited: 78
Development and analysis of an adverse outcome pathway network for human neurotoxicity
Nicoleta Spînu, Anna Bal‐Price, Mark T.D. Cronin, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 10, pp. 2759-2772
Open Access | Times Cited: 77
Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gaps
Thomas Jaylet, Thibaut Coustillet, Nicola Smith, et al.
Frontiers in Toxicology (2024) Vol. 6
Open Access | Times Cited: 9
Advancing the quantitative understanding of Adverse Outcome Pathways: current status, methodologies, and future directions
Jaeseong Jeong, M. D. Gasparyan, Jinhee Choi
Environmental Toxicology and Chemistry (2025)
Closed Access | Times Cited: 1
International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing
Magdalini Sachana, Anna Bal‐Price, Kevin M. Crofton, et al.
Toxicological Sciences (2018) Vol. 167, Iss. 1, pp. 45-57
Closed Access | Times Cited: 65
An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches
Martin Paparella, Susanne Hougaard Bennekou, Anna Bal‐Price
Reproductive Toxicology (2020) Vol. 96, pp. 327-336
Open Access | Times Cited: 62
Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N -methyl- d -aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children
Magdalini Sachana, Alexandra Rolaki, Anna Bal‐Price
Toxicology and Applied Pharmacology (2018) Vol. 354, pp. 153-175
Open Access | Times Cited: 60
Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints
Sabina Halappanavar, Penny Nymark, Harald F. Krug, et al.
Small (2021) Vol. 17, Iss. 15
Open Access | Times Cited: 45
Revolutionizing developmental neurotoxicity testing – a journey from animal models to advanced in vitro systems
Lena Smirnova, Helena T. Högberg, Marcel Leist, et al.
ALTEX (2024)
Open Access | Times Cited: 7
IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept
Luise A. Roser, Christina Sakellariou, Malin Lindstedt, et al.
Journal of Immunotoxicology (2024) Vol. 21, Iss. sup1
Open Access | Times Cited: 6
Screening for Developmental Neurotoxicity at the National Toxicology Program: The Future Is Here
Mamta Behl, Kristen Ryan, Jui‐Hua Hsieh, et al.
Toxicological Sciences (2018) Vol. 167, Iss. 1, pp. 6-14
Open Access | Times Cited: 49
Advancing human health risk assessment
Anna Lanzoni, Anna Federica Castoldi, George E.N. Kass, et al.
EFSA Journal (2019) Vol. 17
Open Access | Times Cited: 45
OECD approaches and considerations for regulatory evaluation of endocrine disruptors
Patience Browne, Leon van der Wal, Anne Gourmelon
Molecular and Cellular Endocrinology (2019) Vol. 504, pp. 110675-110675
Open Access | Times Cited: 44
Biomarkers of effect as determined in human biomonitoring studies on hexavalent chromium and cadmium in the period 2008–2020
Célia Ventura, Bruno Costa Gomes, Axel Oberemm, et al.
Environmental Research (2021) Vol. 197, pp. 110998-110998
Open Access | Times Cited: 34
Quaternary ammonium compounds: perspectives on benefits, hazards, and risk
Thomas G. Osimitz, Wiebke Droege
Toxicology Research and Application (2021) Vol. 5
Open Access | Times Cited: 33
Current status and future directions for a neurotoxicity hazard assessment framework that integrates in silico approaches
Kevin M. Crofton, Arianna Bassan, Mamta Behl, et al.
Computational Toxicology (2022) Vol. 22, pp. 100223-100223
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top